Discover 1,430 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,430
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Riverview FL, Naples FL, West Palm Beach FL,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase2, Recruiting
Active & Responsive
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
for
Obstructive Sleep Apnea (OSA)
Location: Brandon FL, Orlando FL, West Palm Beach FL, Anderson SC,
Sponsor: Incannex Healthcare Ltd
Sex: All
Age: 18 - 65
Code: NCT07635563
Phase2, Recruiting
Active & Responsive
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
for
Insomnia
Location: Bradenton FL, Savannah GA, Charleston SC, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70
Code: NCT06655883
Phase3, Recruiting
Active & Responsive
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Bradenton FL, Naples FL, West Palm Beach FL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07571109
Phase3, Recruiting
Active & Responsive
Investigating Health Impacts of Exposure to Harmful Algal Blooms
for
Red Tide, Neurologic Disorder, Florida
Location: Sarasota FL
Sponsor: Roskamp Institute Inc.
Sex: All
Age: 18+
Code: NCT06883227
Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: